Investor Presentaiton
IV Appendix
Balance Sheet
In EGP
Property & Equipment, net
Other Assets
Project Under Construction
Deferred Income Taxes
Total Long Term Assets
Inventories
(audited)
(audited)
(audited)
(audited)
2014
2015
118,666
152,479
2,840
5,307
2016
171,327
6,667
2017
210,264
8,804
25,864
13,787
47,639
161,267
3,876
6,911
11,704
11,104
151,246
178,485
237,336
391,438
427,320
455,770
611,993
1,050,549
Incoming Documents for Collection
316
442
Trade & Notes receivable, net
1,127,421
1,379,307
2,357
1,946,304
273
2,459,296
Supplier Advances
12,576
30,652
59,951
101,360
Debtors & Other Debit Balance, net
90,029
135,714
153,602
165,718
Due from Related Parties
371
371
372
372
Cash & Cash Equivalent
16,368
32,866
43,880
164,791
Total Current Assets
1,674,402
2,035,123
2,818,459
Total Assets
Paid In Capital
Share Premium
General Reserve
Legal Reserve
Retained Earnings
1,825,648
2,213,607
3,055,796
3,942,358
4,333,796
20,000
24,000
24,000
168,000
0
148,000
0
0
0
0
147,079
3,079
6,334
8,211
12,000
12,000
46,255
13,000
26,944
62,980
Net Profit For The Year
37,541
57,358
101,748
170,137
Total Shareholders' Equity
110,131
250,570
311,771
416,196
Non-current portion of medium term loan
21,978
14,768
29,632
25,083
Non-current notes payable
23,880
35,861
20,312
7,660
Other Non-current liabilities
0
0
11,251
20,815
Non-current portion of land creditors
212
141
71
0
Total Long-term Liabilities
46,070
50,771
61,266
53,559
Credit facilities
Contingency provision
Customers Advance Payments
Current portion of land creditors
Trade and notes payable
206,501
156,686
68,644
6,952
0
600
3,100
24,067
4,757
6,003
6,324
6,453
401
1,001
101
71
1,389,370
1,678,860
2,519,985
3,700,786
Current portion of medium term loan
25,212
24,866
13,112
25,794
Creditors & other credit balances
43,206
44,251
71,492
99,919
Total Current Liabilities
1,669,447
1,912,267
2,682,759
3,864,041
Total Liabilities & Shareholders Equity
1,825,648
2,213,607
3,055,796
4,333,796
Source: Company Management
ibnsinapharma
28View entire presentation